UK-headquartered start-up Tenpoint Therapeutics has reeled in a commendable $70 million in first-round financing that will be used to develop its cell-based therapies for sight-robbing diseases. The ...
As usual, the one-two punch of ASCO and BIO set us a bit behind, but never fear – your June hires round-up is here at least before the end of July. Read on for some of the key appointments of last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback